| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.
|
Immunity
|
2006
|
5.32
|
|
2
|
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.
|
Immunol Rev
|
2004
|
3.98
|
|
3
|
Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
|
Nat Immunol
|
2004
|
3.59
|
|
4
|
Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.
|
Nat Immunol
|
2006
|
3.57
|
|
5
|
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.
|
Proc Natl Acad Sci U S A
|
2006
|
3.19
|
|
6
|
Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
|
Nat Immunol
|
2008
|
2.44
|
|
7
|
Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells.
|
Proc Natl Acad Sci U S A
|
2008
|
1.73
|
|
8
|
The cell biology of cross-presentation and the role of dendritic cell subsets.
|
Immunol Cell Biol
|
2008
|
1.69
|
|
9
|
Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
|
J Immunol
|
2003
|
1.63
|
|
10
|
Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset.
|
Proc Natl Acad Sci U S A
|
2008
|
1.53
|
|
11
|
Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells.
|
J Exp Med
|
2007
|
1.49
|
|
12
|
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.
|
Blood
|
2012
|
1.46
|
|
13
|
Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3.
|
Nat Immunol
|
2013
|
1.45
|
|
14
|
Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
|
Adv Immunol
|
2005
|
1.40
|
|
15
|
DEC-205 is a cell surface receptor for CpG oligonucleotides.
|
Proc Natl Acad Sci U S A
|
2012
|
1.29
|
|
16
|
The acquisition of antigen cross-presentation function by newly formed dendritic cells.
|
J Immunol
|
2011
|
1.29
|
|
17
|
Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells.
|
J Biol Chem
|
2006
|
1.13
|
|
18
|
GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.
|
Eur J Immunol
|
2011
|
1.07
|
|
19
|
Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm.
|
Immunol Cell Biol
|
2004
|
1.00
|
|
20
|
Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens.
|
Proc Natl Acad Sci U S A
|
2007
|
0.96
|
|
21
|
Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways.
|
J Immunol
|
2010
|
0.93
|
|
22
|
Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
|
Autophagy
|
2015
|
0.93
|
|
23
|
Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
|
Eur J Immunol
|
2005
|
0.93
|
|
24
|
A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells.
|
J Immunol
|
2011
|
0.92
|
|
25
|
The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells.
|
Eur J Immunol
|
2012
|
0.92
|
|
26
|
Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells.
|
Eur J Immunol
|
2010
|
0.92
|
|
27
|
IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression.
|
J Immunol
|
2011
|
0.92
|
|
28
|
Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
|
Mol Immunol
|
2011
|
0.91
|
|
29
|
Autophagy and mechanisms of effective immunity.
|
Front Immunol
|
2012
|
0.90
|
|
30
|
Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells.
|
J Immunol
|
2007
|
0.90
|
|
31
|
Is it a DC, is it an NK? No, it's an IKDC.
|
Nat Med
|
2006
|
0.89
|
|
32
|
No driving without a license.
|
Nat Immunol
|
2005
|
0.84
|
|
33
|
Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
|
Eur J Immunol
|
2005
|
0.84
|
|
34
|
Control of MHC II antigen presentation by ubiquitination.
|
Curr Opin Immunol
|
2012
|
0.83
|
|
35
|
Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation.
|
Eur J Immunol
|
2013
|
0.83
|
|
36
|
Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma.
|
Immunol Cell Biol
|
2010
|
0.79
|
|
37
|
Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold.
|
J Immunol
|
2013
|
0.79
|
|
38
|
Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.
|
J Biol Chem
|
2014
|
0.75
|
|
39
|
Introducing this special issue.
|
Mol Immunol
|
2015
|
0.75
|